Antares Pharma (ATRS) Earnings
|
Expand Research on ATRS
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +8.3% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -5.9% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/8/18 | Q118 | -$0.04 | -$0.03 | -$0.01 | $12.7M | $13.3M | = |  | | Details | |
| 3/13/18 | Q417 | -$0.02 | -$0.03 | +$0.01 | $14M | $15.65M | = | | | Details | |
| 11/7/17 |  |
Q317 | -$0.03 | -$0.03 | $0.00 | $15.1M | $13.96M | = | | | Details |
| 8/8/17 | |
Q217 | -$0.02 | -$0.03 | +$0.01 | $13.4M | $12.51M | = | | | Details |
| 5/9/17 | |
Q117 | -$0.03 | -$0.03 | $0.00 | $12M | $12.33M | = | | | Details |
| 3/14/17 | |
Q416 | -$0.03 | -$0.04 | +$0.01 | $14.2M | $11.25M | = | | | Details |
11/9/16  |
|
Q316 | -$0.04 | -$0.03 | -$0.01 | $13.5M | $11.15M | N/A | | | Details |
| 8/9/16 |
|
Q216 | -$0.04 | -$0.04 | $0.00 | $12.2M | $11M | N/A | | | Details |
